FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称LESOFAVUMAB
异名/同义词IMMUNOGLOBULIN G1, ANTI-(INFLUENZA B VIRUS VIRAL HEMAGGLUTININ) (HUMAN MONOCLONAL MHAB5553A HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL MHAB5553A LIGHT CHAIN, DIMER
IMMUNOGLOBULIN G1-KAPPA, ANTI-( INFLUENZA B VIRUS HEMAGGLUTININ)HOMO SAPIENS MONOCLONAL ANTIBODY.GAMMA.1 HEAVY CHAIN (1-453) (HOMO SAPIENS VH (IGHV5-51*01 (90%) (IGHD)-IGHJ5*01 (93%)) (8.8.16) (1-123) -HOMO SAPIENS IGHG1*03 (CH1(R97>K(220)) (124-453)) (226-219')-DISULFIDE WITH .KAPPA. LIGHT CHAIN (1'-219') (HOMO SAPIENS V-KAPPA (IGKV2-28*01 (99%) IGKJ2*01) (11.3.9) (1'-112') -HOMO SAPIENS IGKC*01 (113'-219'))DIMER (232-232'':235-235'')-BISDISULFIDE
LESOFAVUMAB
LESOFAVUMAB [INN]
LESOFAVUMAB [USAN]
MHAB5553A
RG70026
RO7045557
CAS登记号1807960-57-1
物质唯一标识(Unique Ingredient Identifier)J8O0SI025W
分子式
国际化合物标识(International Chemical Identifier,InChI)
SMILES
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型 / INGREDIENT SUBSTANCE
关联数据
  • 药品国际非专利名称数据库
扩展资源
©2006-2026 Drugfuture->FDA Global Substance Registration System